NEW YORK (GenomeWeb News) – In Cell this week, researchers led by the Broad Institute's Stuart Schreiber presented a resource that correlates the genetic characteristics of a few hundred cancer cell lines to their sensitivity to a number of small molecules.

To develop the Cancer Therapeutics Response Portal, Schreiber and his colleagues profiled the sensitivity of 242 genetically characterized cancer cell lines to more than 350 small molecules with well-described targets and activities.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.